Longevity Acquisition Corp
Completed 2021-03-22- CIK 1743858
- LOAC
- IPO 2018-08-29
- $14.6M trust
- 122 filings
Filings, by quarter
122 filings over 16 quarters; dark bars carry a milestone
- 18 Q2: 1 filing
- 18 Q3: 24 filings
- 18 Q4: 5 filings
- 19 Q1: 4 filings
- 19 Q2: 1 filing
- 19 Q3: 3 filings
- 19 Q4: 4 filings
- 20 Q1: 8 filings
- 20 Q2: 10 filings
- 20 Q3: 11 filings
- 20 Q4: 19 filings
- 21 Q1: 29 filings
- 21 Q2: 2 filings
- 21 Q3: 0 filings
- 21 Q4: 0 filings
- 22 Q1: 1 filing
- S-1 filed 18 Q2
- IPO 18 Q3
- Definitive agreement 20 Q4
- Completed 21 Q1
Successfully merged with 4D Pharma plc
SPAC Overview
$40M
IPO Size
$14.6M
Trust (as of 2020-11-30)
Completed
Current Status
2018
IPO Year
Timeline Progress
About
Longevity Acquisition Corporation is a blank-check company seeking an initial business combination, with priority for businesses whose primary operations are in China. It expects to leverage management's financial and operating experience and provide targets access to U.S. capital markets.
Investment Focus
Artificial Intelligence, FinTech, Healthcare, Consumer, Retail, Renewable Energy, Energy, Natural Resources, Food & Beverage, Manufacturing, Education, Technology, Internet of Things
Geographic Focus
China
Key Information
IPO Date
2018-08-29
Jurisdiction of Incorporation
British Virgin Islands
SIC
6770
Completion Date
2021-03-22
Merger Target
4D Pharma plc
SPAC Ticker
LOAC
SPAC Team
Underwriters
Extended Team Information
Experienced financial services and accounting professionals and senior operating executives of companies in China, with decades of M&A and operating-company experience.